Cargando…

HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis

BACKGROUND: Hepatitis C virus (HCV) and HIV are both transmitted through percutaneous exposures among people who inject drugs (PWID). Ecological analyses on global epidemiological data have identified a positive association between HCV and HIV prevalence among PWID. Our objective was to demonstrate...

Descripción completa

Detalles Bibliográficos
Autores principales: Akbarzadeh, Vajiheh, Mumtaz, Ghina R., Awad, Susanne F., Weiss, Helen A., Abu-Raddad, Laith J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135754/
https://www.ncbi.nlm.nih.gov/pubmed/27912737
http://dx.doi.org/10.1186/s12889-016-3887-y
_version_ 1782471600803676160
author Akbarzadeh, Vajiheh
Mumtaz, Ghina R.
Awad, Susanne F.
Weiss, Helen A.
Abu-Raddad, Laith J.
author_facet Akbarzadeh, Vajiheh
Mumtaz, Ghina R.
Awad, Susanne F.
Weiss, Helen A.
Abu-Raddad, Laith J.
author_sort Akbarzadeh, Vajiheh
collection PubMed
description BACKGROUND: Hepatitis C virus (HCV) and HIV are both transmitted through percutaneous exposures among people who inject drugs (PWID). Ecological analyses on global epidemiological data have identified a positive association between HCV and HIV prevalence among PWID. Our objective was to demonstrate how HCV prevalence can be used to predict HIV epidemic potential among PWID. METHODS: Two population-level models were constructed to simulate the evolution of HCV and HIV epidemics among PWID. The models described HCV and HIV parenteral transmission, and were solved both deterministically and stochastically. RESULTS: The modeling results provided a good fit to the epidemiological data describing the ecological HCV and HIV association among PWID. HCV was estimated to be eight times more transmissible per shared injection than HIV. A threshold HCV prevalence of 29.0% (95% uncertainty interval (UI): 20.7-39.8) and 46.5% (95% UI: 37.6-56.6) were identified for a sustainable HIV epidemic (HIV prevalence >1%) and concentrated HIV epidemic (HIV prevalence >5%), respectively. The association between HCV and HIV was further described with six dynamical regimes depicting the overlapping epidemiology of the two infections, and was quantified using defined and estimated measures of association. Modeling predictions across a wide range of HCV prevalence indicated overall acceptable precision in predicting HIV prevalence at endemic equilibrium. Modeling predictions were found to be robust with respect to stochasticity and behavioral and biological parameter uncertainty. In an illustrative application of the methodology, the modeling predictions of endemic HIV prevalence in Iran agreed with the scale and time course of the HIV epidemic in this country. CONCLUSIONS: Our results show that HCV prevalence can be used as a proxy biomarker of HIV epidemic potential among PWID, and that the scale and evolution of HIV epidemic expansion can be predicted with sufficient precision to inform HIV policy, programming, and resource allocation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12889-016-3887-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5135754
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51357542016-12-15 HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis Akbarzadeh, Vajiheh Mumtaz, Ghina R. Awad, Susanne F. Weiss, Helen A. Abu-Raddad, Laith J. BMC Public Health Research Article BACKGROUND: Hepatitis C virus (HCV) and HIV are both transmitted through percutaneous exposures among people who inject drugs (PWID). Ecological analyses on global epidemiological data have identified a positive association between HCV and HIV prevalence among PWID. Our objective was to demonstrate how HCV prevalence can be used to predict HIV epidemic potential among PWID. METHODS: Two population-level models were constructed to simulate the evolution of HCV and HIV epidemics among PWID. The models described HCV and HIV parenteral transmission, and were solved both deterministically and stochastically. RESULTS: The modeling results provided a good fit to the epidemiological data describing the ecological HCV and HIV association among PWID. HCV was estimated to be eight times more transmissible per shared injection than HIV. A threshold HCV prevalence of 29.0% (95% uncertainty interval (UI): 20.7-39.8) and 46.5% (95% UI: 37.6-56.6) were identified for a sustainable HIV epidemic (HIV prevalence >1%) and concentrated HIV epidemic (HIV prevalence >5%), respectively. The association between HCV and HIV was further described with six dynamical regimes depicting the overlapping epidemiology of the two infections, and was quantified using defined and estimated measures of association. Modeling predictions across a wide range of HCV prevalence indicated overall acceptable precision in predicting HIV prevalence at endemic equilibrium. Modeling predictions were found to be robust with respect to stochasticity and behavioral and biological parameter uncertainty. In an illustrative application of the methodology, the modeling predictions of endemic HIV prevalence in Iran agreed with the scale and time course of the HIV epidemic in this country. CONCLUSIONS: Our results show that HCV prevalence can be used as a proxy biomarker of HIV epidemic potential among PWID, and that the scale and evolution of HIV epidemic expansion can be predicted with sufficient precision to inform HIV policy, programming, and resource allocation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12889-016-3887-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-12-03 /pmc/articles/PMC5135754/ /pubmed/27912737 http://dx.doi.org/10.1186/s12889-016-3887-y Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Akbarzadeh, Vajiheh
Mumtaz, Ghina R.
Awad, Susanne F.
Weiss, Helen A.
Abu-Raddad, Laith J.
HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis
title HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis
title_full HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis
title_fullStr HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis
title_full_unstemmed HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis
title_short HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis
title_sort hcv prevalence can predict hiv epidemic potential among people who inject drugs: mathematical modeling analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135754/
https://www.ncbi.nlm.nih.gov/pubmed/27912737
http://dx.doi.org/10.1186/s12889-016-3887-y
work_keys_str_mv AT akbarzadehvajiheh hcvprevalencecanpredicthivepidemicpotentialamongpeoplewhoinjectdrugsmathematicalmodelinganalysis
AT mumtazghinar hcvprevalencecanpredicthivepidemicpotentialamongpeoplewhoinjectdrugsmathematicalmodelinganalysis
AT awadsusannef hcvprevalencecanpredicthivepidemicpotentialamongpeoplewhoinjectdrugsmathematicalmodelinganalysis
AT weisshelena hcvprevalencecanpredicthivepidemicpotentialamongpeoplewhoinjectdrugsmathematicalmodelinganalysis
AT aburaddadlaithj hcvprevalencecanpredicthivepidemicpotentialamongpeoplewhoinjectdrugsmathematicalmodelinganalysis